GLUTag cells are a stable immortalized murine enteroendocrine cell line that express the glucagon gene and secretes the glucagon-like peptides in a regulated manner

This cell line was isolated from a glucagon-producing enteroendocrine cell tumor that arose in glucagon gene-SV40 T antigen transgenic mice Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J Biol Chem. 1992 May 25;267 (15): 10705-8

GLUTag cells have been serially passaged in nude mice, and give rise to glucagonomas that exhibit a stable phenotype of glucagon gene expression over a 4-8 week period as shown in Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor. Mol Endocrinol. 1992 Dec;6(12):2175-84.

In contrast to mouse STC-1 cells, GLUTag cells appear quite well differentiated, and recapitulate the responsiveness of primary non-transformed rat intestinal cell cultures to physiological and pharmacological secretagogues as demonstrated in Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol. 1994 Dec;8(12):1646-55 and Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology. 1998 Oct;139(10):4108-14.

Gribble and colleagues used a transgenic approach to isolate non-transformed L cells using a fluorescent protein expressed in L cells under the control of the proglucagon promoter. Isolated sorted GLP-1-secreting L cells were analyzed in primary culture. These cells were directly glucose-responsive, and secreted GLP-1 in response to agents causing membrane depolarization or neurotransmitter-stimulated signal transduction. Moreover, comparison of key genes and proteins expressed in and signal transduction pathways operative in L cells with the same genes, proteins, and pathways utilized by the GLUTag cell line revealed remarkable similarities between non-immortalized L cells and GLUTag cells. Remarkably, primary mouse L cell cultures and GLUTag cells exhibit a similar Ec50 for glucose stimulation of GLP-1 secretion, comparable responsivity to forskolin/IBMX and bomesin and very similar patterns of gene expression profiles for key receptors, glucose sensorss, ion channels, and regulatory molecules (Figure 4 and Table S1); See Glucose sensing in L cells: a primary cell study Cell Metab. 2008 Dec;8(6):532-9

GLUTag cells have been utilized extensively for the analysis of GLP-1/GLP-2 secretagogues, and for studies of enteroendocrine glucagon gene transcription. 

GLUTag cells have also been studied for analysis of CCK biosynthesis and secretion.

GLUTag cells have been propagated intermittently since 1991 in the Drucker lab, and early passage cells have retained their differentiated phenotype both in vitro and in vivo. Indeed, independent studies carried out over a decade later reveal preserved glucose competence, with GLP-1 secretion stimulated over a range of glucose concentrations, likely via closure of KATP channels, as shown in Glucose-sensing in glucagon-like Peptide-1-secreting cells. Diabetes. 2002 Sep;51(9):2757-63.

Furthermore, GLUTag cells control GLP-1 secretion in part through depolarization events triggered not only by metabolizable sugars (glucose or fructose) but also by through non-metabolizable sugars through a SGLT-dependent mechanism, as outlined in A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line. Diabetes. 2003 May;52(5):1147-54

Moreover, glutamine has also been shown to be a potent secretagogue in GLP-1 release as outlined in Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia. 2004 Sep;47(9):1592-601. Epub 2004 Sep

Similarly, Reimann, Gribble and colleagues have characterized ion channel current and channel expression in GLUTag cells.  These studies demonstrated that GLP-1 release in GLUTag cells is not dependent on the firing of Na(+)-carrying action potentials but requires membrane depolarisation and Ca(2+) entry through L-type Ca(2+) channels. See Characterisation and functional role of voltage gated cation conductances in the Glucagon-like peptide-1 secreting GLUTag cell line. J Physiol. 2004 Dec 20; [Epub ahead of print]

Analysis of GLP-1 secretion in GLUTag cells indicates that peptides or pharmacological agents that increase cyclic AMP also increase levels of intracellular calcium, events coupled to stimulation of GLP-1 secretion in GLUTag cells.  Enhanced levels of cyclic AMP appear to sensitize the L cells to nutrient-related secretagogues such as glucose See Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia. 2007 Jul 21; [Epub ahead of print]

To review some of the GLUTag cell literature, See:

Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor. Mol Endocrinol. 1992 Dec;6(12):2175-84.

Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice. Am J Physiol. 1994 Nov;267(5 Pt 1):E629-35. Review.

Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol. 1994 Dec;8(12):1646-55

The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcription. Mol Endocrinol. 1995 Oct;9(10):1306-20.

The caudal homeobox protein cdx-2/3 activates endogenous proglucagon gene expression in InR1-G9 islet cells. Mol Endocrinol. 1997 Feb;11(2):203-9.

Peptones stimulate cholecystokinin secretion and gene transcription in the intestinal cell line STC-1. Endocrinology. 1997 Mar;138(3):1137-44.

Expression of SNARE proteins in enteroendocrine cell lines and functional role of tetanus toxin-sensitive proteins in cholecystokinin release. FEBS Lett. 1998 Mar 20;425(1):66-70.

Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes. 1998 Jul;47(7):1038-45

Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology. 1998 Oct;139(10):4108-14

Divergent regulation of human and rat proglucagon gene promoters in vivo. Am J Physiol. 1999 Oct;277(4 Pt 1):G829-37

Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J Physiol. 2000 Oct 1;528 Pt 1:165-76

Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells. Endocrinology. 2001 Jan;142(1):37-42.

Rab3a controls exocytosis in cholecystokinin-secreting cells. FEBS Lett. 2001 Aug 10;503(1):19-24

Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression. Biochem J. 2002 Sep 1;366(Pt 2):633-41.

Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes. 2002 Sep;51(9):2757-63

Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine. Mol Endocrinol. 2002 Oct;16(10):2349-59

Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells. J Biol Chem. 2003 Jan 10;278(2):1380-7.

Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes. 2003 Feb;52(2):252-9

A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line. Diabetes. 2003 May;52(5):1147-54

Differentiation phenotypes of pancreatic islet beta- and alpha-cells are closely related with homeotic genes and a group of differentially expressed genes. Gene. 2004 Apr 28;331:53-63

TCF-4 mediates cell-type specific regulation of proglucagon gene expression by beta-catenin and GSK-3beta. J Biol Chem. 2004 Nov 2; [Epub ahead of print]

Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia. 2004 Sep;47(9): 1592-601. Epub 2004 Sep

Pdx-1 is not sufficient for repression of proglucagon gene transcription in islet or enteroendocrine cells. Endocrinology. 2005 Jan;146(1):441-9. Epub 2004 Oct 07

TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem. 2005 Jan 14;280(2):1457-64

Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line. J Physiol. 2005 Feb 15;563(Pt 1):161-75

PKA independent and cell type specific activation of the expression of caudal homeobox gene Cdx-2 by cyclic AMP. FEBS J. 2005 Jun;272(11):2746-59

The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line. J Physiol. 2005 Dec 15;569(Pt 3):761-72.

Vesicular storage and secretion of l-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells. J Neurochem. 2006 Jan;96(2):550-60.

Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology. 2007 Mar;148(3):1089-98. Epub 2006 Nov 16.

Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia. 2007 Jul 21; [Epub ahead of print]

T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15075-80. Epub 2007 Aug 27

A Role for Intestinal Endocrine Cell-Expressed GPR119 in Glycemic Control by Enhancing GLP-1 and GIP Release Endocrinology. 2008 Jan 17; 2008 May;149(5):2038-47.

Cross Talk between the Insulin and Wnt Signaling Pathways: Evidence from Intestinal Endocrine L Cells Endocrinology. 2008 May;149(5):2341-51.

Insulin-secreting L-cells for the treatment of insulin-dependent diabetes  Biochem Biophys Res Commun. 2008 Jun 20;371(1):39-43

Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology. 2009 Feb;150(2):580-91. Epub 2008 Sep 25

Epac is involved in cAMP-stimulated proglucagon expression and hormone production, but not hormone secretion in pancreatic alpha and intestinal L cell lines. Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E174-81. Epub 2008 Oct 14

Glucose sensing in L cells: a primary cell study Cell Metab. 2008 Dec;8(6):532-9

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell Diabetes. 2009 May;58(5):1058-66. Epub 2009 Feb 10.

Development and characterization of a tissue engineered pancreatic substitute based on recombinant intestinal endocrine L-cells Biotechnol Bioeng. 2009 Jul 1;103(4):828-34.

A selective small molecule GLP-1 secretagogue acting via depolarization and Ca2+ influx J Endocrinol. 2009 Jun;201(3):361-7. Epub 2009 Mar 30

 

The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release Br J Pharmacol. 2009 Jun;157(4):633-44. Epub 2009 Apr 9.

GLP-1 secretion is enhanced directly in the ileum, but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate in rats Am J Physiol Gastrointest Liver Physiol. 2009 Aug 6. [Epub ahead of print]

Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion. Biochem Biophys Res Commun. 2009 Sep 1. [Epub ahead of print]

The Rho Guanosine 5'-Triphosphatase, Cell Division Cycle 42, Is Required for Insulin-Induced Actin Remodeling and Glucagon-Like Peptide-1 Secretion in the Intestinal Endocrine L Cell. Endocrinology. 2009 Oct 9. [Epub ahead of print]

A Cell-Based Approach for Diabetes Treatment Using Engineered Non-beta Cells. J Diabetes Sci Technol. 2009 May 1;3(3):555-561.